NIH-funded research R01 grant

How benzene exposure affects heart health

Official title: Vascular Toxicity of Benzene

Funded at University of Louisville · NIH-11040320 · Data updated 2026-11-12

This study is looking at how exposure to benzene, which is found in air pollution and tobacco smoke, can make heart problems like atherosclerosis worse, and it aims to find ways to protect your heart from these harmful effects.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Louisville
NIH-funded
Lab location1 site (Louisville, United States)
Project startFebruary 21, 2024
Project endNovember 30, 2028
Funding year2025
Award (this year)$664,616
NIH project number5R01ES033531-02
Project IDNIH-11040320 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a history of high benzene exposure, such as those living near industrial sites or with occupational exposure.

Less likely to help

Patients who have no history of benzene exposure or those with unrelated cardiovascular conditions may not benefit from this research.

What this research studies

This research investigates the cardiovascular toxicity of benzene, a common environmental pollutant found in air pollution and tobacco smoke. It focuses on how benzene exposure can worsen atherosclerosis, a major cause of heart disease and stroke. The study employs advanced techniques like RNA sequencing to identify molecular targets affected by benzene, including specific proteins that may either contribute to or protect against heart damage. By understanding these mechanisms, the research aims to uncover potential therapeutic targets for mitigating the harmful effects of benzene on cardiovascular health.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating cardiovascular diseases linked to benzene exposure.

How similar studies have gone: Previous studies have indicated that environmental pollutants like benzene can have significant adverse effects on cardiovascular health, suggesting that this research builds on established findings.

Where this research is happening

  • University of Louisville
    Louisville, United States
    Active

Researchers

  • Principal investigator: Srivastava, Sanjay — University of Louisville
  • Study coordinator: Srivastava, Sanjay

Related research

Other NIH-funded projects on the same topics.

  • Gastric rhythm map to understand stomach problems using a new noninvasive tool

    A new noninvasive body surface mapping method is being tested to see if abnormal stomach electrical rhythms explain chronic stomach problems like functional dyspepsia and persistent nausea.

    NIH research University of Louisville · Louisville, United States · NIH-11611507

  • Novel antivirals for alphavirus arthritis

    A research team is refining a promising antiviral compound to treat alphavirus infections that cause arthritis, with a focus on Chikungunya and related viruses.

    NIH research University of Louisville · Louisville, United States · NIH-11609180

  • Linking heavy metal exposure to a tougher breast cancer type (TNBC)

    Aimed at understanding how heavy metals like cadmium might trigger a dangerous breast cancer type (TNBC) in people, especially those with BRCA1 risk, to identify possible future treatment strategies.

    NIH research University of Louisville · Louisville, United States · NIH-11567535

  • Cardiac safety of flavored e-cigarette aerosols in adults

    A pharmacist or clinician would test how inhaling flavored e-cigarette aerosols affects heart rhythm in adults to see if flavors raise the risk of heart problems.

    NIH research University of Louisville · Louisville, United States · NIH-11541950

  • Biomedical Research Facilities to Expand Precision Medicine in Kentucky

    A large NIH grant aims to renovate and expand a shared precision medicine center in Kentucky to speed up research that could improve health for people in Appalachia and surrounding areas.

    NIH research University of Louisville · Louisville, United States · NIH-11523167

  • Rac-enhanced CAR-Macrophages against TNBC

    A new cell therapy approach uses engineered macrophages with a CAR and Rac2 activation to target and kill triple-negative breast cancer cells expressing CSPG4.

    NIH research University of Louisville · Louisville, United States · NIH-11520503

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.